The major aim of all vaccination strategies is disease reduction goals by getting high levels of immunity in the targeted group of people via adequate vaccination coverage and vaccine effectiveness. The idea is to boost immune system of individuals to prevent the spread of the disease.
These are some different type of vaccination strategies given below:
Pulse vaccination strategy: The pulse vaccination strategy is the process used to eliminate an epidemic by repeatedly vaccinating a group of people at risk, over a defined age range, until the spread of the microbe has been come to an end. It is mostly used during the time of polio and measles epidemics to quickly end the spread and contain the outbreak.
Ring vaccination: The method of vaccination of all infected individuals in a prescribed area around an outbreak of an infectious disease. The Ring vaccination process helps to controls an outbreak by monitoring and vaccinating a ring of people around each infected individual. The idea is to boost immune system of individuals to prevent the spread of the disease.
Cocooning (immunization): Cocooning process also known as the Cocoon Strategy, is an immunization strategy to protect young child and other vulnerable individuals from the infectious diseases by vaccinating those who are in close contact with them. If the groups of people most likely to transmit an infection are immune, their immunity creates a "cocoon" of protection around the newborn or the vulnerable persons.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy